Thorne Healthtech, Inc. THRN
We take great care to ensure that the data presented and summarized in this overview for Thorne Healthtech, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in THRN
Top Purchases
Top Sells
About THRN
Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits for its customers, as well as develops nutritional supplements and offers wellness education solutions. The company uses the Onegevity platform to map, integrate, and understand the biological features that describe the state of an individual's health, as well as provide actionable insights and personalized data, products, and services that help individuals to take a proactive approach to improve and maintain their health. It primarily serves healthcare professionals, professional athletes, and professional sports and Olympic teams. Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York.
Insider Transactions at THRN
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 16
2023
|
Thomas P. Mc Kenna Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,172,227
-100.0%
|
-
|
|
Oct 16
2023
|
Saloni S. Varma Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
581,643
-100.0%
|
-
|
|
Oct 16
2023
|
Riccardo Braglia Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
5,424,550
-100.0%
|
-
|
|
Oct 16
2023
|
Paul F Jacobson Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
1,822,822
-100.0%
|
-
|
|
Oct 16
2023
|
Paul F Jacobson Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,105,589
-100.0%
|
-
|
|
Oct 16
2023
|
Sarah M Kauss Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
105,874
-100.0%
|
-
|
|
Oct 16
2023
|
William C. Mc Camy President |
SELL
Sale (or disposition) back to the issuer
|
Direct |
589,804
-100.0%
|
-
|
|
Oct 16
2023
|
Mitsui & CO LTD > 10% Shareholder |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
15,674,235
-100.0%
|
-
|
|
Oct 12
2023
|
Kirin Holdings Company, LTD /Fi > 10% Shareholder |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
15,674,235
-100.0%
|
$156,742,350
$10.2 P/Share
|
|
Jun 29
2023
|
Paul F Jacobson Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
220,377
-9.43%
|
-
|
|
Apr 04
2023
|
Saloni S. Varma Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
500,000
+46.35%
|
-
|
|
Apr 04
2023
|
Saloni S. Varma Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,430
-7.56%
|
$25,720
$4.72 P/Share
|
|
Apr 04
2023
|
Paul F Jacobson Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
500,000
+17.62%
|
-
|
|
Apr 04
2023
|
Paul F Jacobson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
40,556
-2.16%
|
$162,224
$4.72 P/Share
|
|
Apr 04
2023
|
Sarah M Kauss Director |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+22.08%
|
-
|
|
Apr 04
2023
|
William C. Mc Camy President |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+25.32%
|
-
|
|
Apr 04
2023
|
William C. Mc Camy President |
SELL
Payment of exercise price or tax liability
|
Direct |
7,609
-1.91%
|
$30,436
$4.72 P/Share
|
|
Apr 04
2023
|
Thomas P. Mc Kenna Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
400,000
+25.44%
|
-
|
|
Apr 04
2023
|
Thomas P. Mc Kenna Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
23,513
-2.96%
|
$94,052
$4.72 P/Share
|
|
Mar 24
2023
|
Paul F Jacobson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
52,619
-2.72%
|
$210,476
$4.7 P/Share
|
Last 12 Months Summary
| Sale (or disposition) back to the issuer | 11.8M shares |
|---|---|
| Disposition due to a tender of shares in a change of control transaction | 31.3M shares |